Cargando…
Current Status and Challenges Associated with CNS-Targeted Gene Delivery across the BBB
The era of the aging society has arrived, and this is accompanied by an increase in the absolute numbers of patients with neurological disorders, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). Such neurological disorders are serious costly diseases that have a significant impact on s...
Autores principales: | Kimura, Seigo, Harashima, Hideyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765480/ https://www.ncbi.nlm.nih.gov/pubmed/33334049 http://dx.doi.org/10.3390/pharmaceutics12121216 |
Ejemplares similares
-
Non-invasive gene delivery across the blood-brain barrier: present and future perspectives
por: Kimura, Seigo, et al.
Publicado: (2021) -
mRNA-Loaded Lipid Nanoparticles Targeting Immune Cells in the Spleen for Use as Cancer Vaccines
por: Shimosakai, Ryoya, et al.
Publicado: (2022) -
Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood–Brain Barrier (BBB)
por: Ghorai, Soma Mondal, et al.
Publicado: (2023) -
Current approaches to enhance CNS delivery of drugs across the brain barriers
por: Lu, Cui-Tao, et al.
Publicado: (2014) -
Non-Invasive, Targeted Nanoparticle-Mediated Drug Delivery across a Novel Human BBB Model
por: Kaya, Shona, et al.
Publicado: (2023)